SYNLOGIC, INC. (Nasdaq:SYBX)
Health Care/Life Sciences • Biotechnology
CIK 1527599
Company
Synlogic, Inc. engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded by James J. Collins and Timothy K. Lu on August 28, 2017, and is headquartered in Cambridge, MA.
Address
301 Binney Street
Suite 402
Cambridge, Massachusetts 02142
301 Binney Street
Suite 402
Cambridge, Massachusetts 02142
Employees
72
72
Stock Info
Close
$1.8500
$1.8500
Day Range
1.7900 - 1.9100
1.7900 - 1.9100
52 Week Range
1.5500 - 11.0220
1.5500 - 11.0220
Average volume
142.33K
142.33K
Short Interest
20.73K (02/29/24)
20.73K (02/29/24)
% of Float Shorted
0.42%
0.42%
Market Cap
$16.82M
$16.82M
Revenue
$1.18M
$1.18M
Net Income
-$66.15M
-$66.15M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director Aoife M Brennan MD |
Chairman Peter Barrett PhD |
Independent Director Michael Thomas Heffernan |
Independent Director Michael M Burgess MD, PhD |
Independent Director Patricia N Hurter PhD |
Independent Director Richard P Shea MBA, CPA |
Independent Director Nick Leschly MBA |
Independent Director Edward T Mathers |
Independent Director Lisa Kelly-Croswell |
SEC filings
Date | Form | Event |
---|---|---|
8 Aug, 2024 | 8-K | |
8 Aug, 2024 | 10-Q | |
16 May, 2024 | SC 13D/A | |
14 May, 2024 | 10-Q | |
14 May, 2024 | 8-K | |
29 Apr, 2024 | 10-K/A | |
22 Apr, 2024 | 144 | |
18 Apr, 2024 | SC 13G | |
4 Apr, 2024 | 4 | |
4 Apr, 2024 | 4 | |
21 Mar, 2024 | 3 | |
21 Mar, 2024 | 144 | |
21 Mar, 2024 | 3 | |
21 Mar, 2024 | 4 | |
21 Mar, 2024 | 8-K | |
19 Mar, 2024 | 8-K | |
19 Mar, 2024 | 10-K | |
22 Feb, 2024 | 8-K | CEO Change |
20 Feb, 2024 | 8-K | |
20 Feb, 2024 | 8-A12B | |
16 Feb, 2024 | SC 13D | |
16 Feb, 2024 | 3 | |
14 Feb, 2024 | SC 13G/A | |
14 Feb, 2024 | SC 13G | |
12 Feb, 2024 | 8-K | CEO Change |
9 Feb, 2024 | SC 13G/A | |
4 Jan, 2024 | 4 | |
4 Jan, 2024 | 4 | |
29 Dec, 2023 | 8-K | |
17 Nov, 2023 | 8-K | |
15 Nov, 2023 | 8-K | |
14 Nov, 2023 | 4 | |
14 Nov, 2023 | 4 | |
14 Nov, 2023 | 4 | |
9 Nov, 2023 | 8-K | |
9 Nov, 2023 | 10-Q | |
7 Nov, 2023 | 8-K | |
13 Oct, 2023 | SC 13D/A | |
13 Oct, 2023 | SC 13G/A | |
10 Oct, 2023 | SC 13G/A | |
6 Oct, 2023 | 3 | |
4 Oct, 2023 | SC 13D/A | |
2 Oct, 2023 | 424B4 | |
29 Sep, 2023 | 8-K | |
28 Sep, 2023 | S-1MEF | |
28 Sep, 2023 | EFFECT | |
28 Sep, 2023 | 8-K | |
28 Sep, 2023 | S-1/A | |
27 Sep, 2023 | S-1/A | |
26 Sep, 2023 | CORRESP | |
26 Sep, 2023 | CORRESP | |
25 Sep, 2023 | UPLOAD | |
22 Sep, 2023 | 8-K | |
20 Sep, 2023 | CORRESP | |
15 Sep, 2023 | UPLOAD | |
11 Sep, 2023 | UPLOAD | |
8 Sep, 2023 | S-1 | |
1 Sep, 2023 | DEF 14A | |
21 Aug, 2023 | PRE 14A | |
16 Aug, 2023 | 8-K | |
10 Aug, 2023 | 10-Q | |
10 Aug, 2023 | 8-K | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
26 Jun, 2023 | 4 | |
15 Jun, 2023 | 8-K | |
5 Jun, 2023 | 8-K | |
11 May, 2023 | 8-K | |
11 May, 2023 | 10-Q | |
1 May, 2023 | ARS | |
1 May, 2023 | DEFA14A | |
1 May, 2023 | DEF 14A | |
21 Apr, 2023 | PRE 14A | |
5 Apr, 2023 | 4 | |
5 Apr, 2023 | 4 | |
5 Apr, 2023 | 4 | |
4 Apr, 2023 | 424B5 | |
29 Mar, 2023 | 10-K | |
29 Mar, 2023 | S-8 | |
29 Mar, 2023 | 8-K | |
29 Mar, 2023 | S-8 | |
14 Feb, 2023 | SC 13G/A | |
9 Feb, 2023 | SC 13G/A | |
20 Jan, 2023 | SC 13G/A | |
20 Jan, 2023 | SC 13G | |
19 Jan, 2023 | 8-K | |
4 Jan, 2023 | 4 | |
4 Jan, 2023 | 4 | |
15 Dec, 2022 | 8-K | |
9 Dec, 2022 | 8-K | |
30 Nov, 2022 | 8-K | |
23 Nov, 2022 | 8-K | |
10 Nov, 2022 | 10-Q | |
10 Nov, 2022 | 8-K | |
18 Oct, 2022 | 8-K | |
6 Sep, 2022 | 8-K | |
11 Aug, 2022 | 8-K | |
11 Aug, 2022 | 10-Q | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 4 | |
13 Jun, 2022 | 8-K | |
25 May, 2022 | 4 | |
12 May, 2022 | 10-Q | |
12 May, 2022 | 8-K | |
27 Apr, 2022 | DEF 14A | |
27 Apr, 2022 | DEFA14A | |
6 Apr, 2022 | 4 | |
6 Apr, 2022 | 4 | |
17 Mar, 2022 | S-8 | |
17 Mar, 2022 | 8-K | |
17 Mar, 2022 | S-8 | |
17 Mar, 2022 | 10-K | |
3 Mar, 2022 | 4 | |
3 Mar, 2022 | 3 | |
3 Mar, 2022 | 8-K | |
9 Feb, 2022 | SC 13G/A | |
8 Feb, 2022 | 4 | |
8 Feb, 2022 | 4 | |
1 Feb, 2022 | 4 | |
24 Jan, 2022 | 8-K | |
5 Jan, 2022 | 4 | |
10 Nov, 2021 | 8-K | |
10 Nov, 2021 | 10-Q | |
9 Nov, 2021 | 8-K | |
1 Oct, 2021 | SC 13G | |
29 Sep, 2021 | SC 13D/A | |
23 Sep, 2021 | 424B5 | |
23 Sep, 2021 | 8-K | |
22 Sep, 2021 | 424B5 | |
20 Sep, 2021 | 8-K | |
12 Aug, 2021 | 8-K | |
12 Aug, 2021 | 10-Q | |
30 Jul, 2021 | EFFECT | |
30 Jul, 2021 | 8-K | |
29 Jul, 2021 | CORRESP | |
28 Jul, 2021 | UPLOAD | |
23 Jul, 2021 | S-3 | |
15 Jul, 2021 | 8-K | |
17 Jun, 2021 | 8-K | |
14 Jun, 2021 | 4 | |
14 Jun, 2021 | 4 | |
14 Jun, 2021 | 4 | |
14 Jun, 2021 | 4 | |
14 Jun, 2021 | 4 | |
14 Jun, 2021 | 4 | |
14 Jun, 2021 | 4 | |
14 Jun, 2021 | 4 | |
11 Jun, 2021 | 8-K | |
13 May, 2021 | 8-K | |
13 May, 2021 | 10-Q | |
10 May, 2021 | SC 13G | |
5 May, 2021 | 8-K | |
27 Apr, 2021 | DEFA14A | |
27 Apr, 2021 | DEF 14A | |
22 Apr, 2021 | SC 13D/A | |
22 Apr, 2021 | 4 | |
22 Apr, 2021 | 4 | |
19 Apr, 2021 | 424B5 | |
16 Apr, 2021 | 8-K | |
15 Apr, 2021 | 424B5 | |
14 Apr, 2021 | 8-K | |
29 Mar, 2021 | SC 13D/A | |
25 Mar, 2021 | S-8 | |
25 Mar, 2021 | 8-K | |
25 Mar, 2021 | S-8 | |
25 Mar, 2021 | 10-K | |
24 Mar, 2021 | 8-K | |
12 Mar, 2021 | 4 | |
12 Mar, 2021 | 4 | |
12 Mar, 2021 | 4 | |
8 Mar, 2021 | 8-K | |
11 Feb, 2021 | 3 | |
11 Feb, 2021 | 4 | |
10 Feb, 2021 | 8-K | |
10 Feb, 2021 | 424B5 | |
5 Jan, 2021 | 4 |
Last update:2024-03-12 12:02:43.316528
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.